TIDMAGY

RNS Number : 8466B

Allergy Therapeutics PLC

12 January 2015

12 January 2015

Allergy Therapeutics plc

("Allergy Therapeutics"or the 'Company")

Trading Update

Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, will announce its unaudited interim results for the 6 months ended 31 December 2014 on 2 March 2015.

The Company expects to report revenue growth of 11% for the period at constant currency, with first half revenues of approximately GBP30.2m (H1 2014: GBP27.2m). This double digit sales growth has been driven primarily by the Company's improving trading performance as it continues to increase its market share in all of its main markets.

First half reported revenues are expected to be approximately GBP28.2m (H1 2014: GBP27.2m), representing growth of 4% taking into account currency impacts; the negative impact from the weakening Euro being GBP2.0m.

Manuel Llobet, Chief Executive Officer, said:

"Despite flat markets, we have been able to grow double digit at constant currency by increasing our market share, particularly in Germany and the Netherlands, thanks to our winning range of short course aluminium free allergy vaccines."

 
 Allergy Therapeutics                            +44 (0) 1903 845 820 
 Manuel Llobet, Chief Executive Officer 
 Ian Postlethwaite, Finance Director 
 
 Panmure Gordon                                  +44 (0) 20 7886 2500 
 Freddy Crossley / Duncan Monteith, Corporate 
  Finance 
 Tom Salvesen, Corporate Broking 
 
 FTI Consulting                                  +44 (0) 20 3727 1000 
 Simon Conway 
 Victoria Foster Mitchell

Note to editors

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of GBP42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTLIFVILEIFLIE

Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Allergy Therapeutics Charts.
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Allergy Therapeutics Charts.